WhaleCreep
Home › Funds › Tri Locum Partners LP › Q3 2024

Tri Locum Partners LP 13F holdings, Q3 2024

Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →

Tri Locum Partners LP disclosed 20 US equity positions worth $417.4m in its Q3 2024 13F filing. The largest position was PFE at 12.0% of the reported book, followed by TEVA and NTRA.

· Q4 2024 →

What did Tri Locum Partners LP own in Q3 2024? Top 20 positions

#StockSectorWeightValueSharesΔ sharesvs prior
1 PFE PFIZER INC Healthcare 12.0%$50.2m1,732,935 –
2 TEVA TEVA PHARMACEUTICAL INDS LTD Healthcare 11.9%$49.7m2,755,737 –
3 NTRA NATERA INC Healthcare 9.7%$40.3m317,439 –
4 STVN STEVANATO GROUP S P A 9.0%$37.4m1,867,938 –
5 ARGX ARGENX SE Healthcare 8.1%$33.9m62,474 –
6 INSP INSPIRE MED SYS INC Healthcare 7.7%$32.0m151,429 –
7 PCVX VAXCYTE INC Healthcare 7.4%$31.1m271,922 –
8 AVADEL PHARMACEUTICALS PLC 5.2%$21.8m1,660,955 –
9 UTHR UNITED THERAPEUTICS CORP DEL Healthcare 4.7%$19.7m54,926 –
10 LEGN LEGEND BIOTECH CORP Healthcare 4.2%$17.7m362,270 –
11 VRNA VERONA PHARMA PLC 4.1%$17.1m593,980 –
12 INSM INSMED INC Healthcare 2.5%$10.5m143,920 –
13 BHVN BIOHAVEN LTD Healthcare 2.3%$9.7m193,195 –
14 MERUS N V 2.3%$9.6m192,157 –
15 BRD1EUR MIND MEDICINE MINDMED INC 2.3%$9.5m1,662,953 –
16 MDGL MADRIGAL PHARMACEUTICALS INC Healthcare 2.2%$9.2m43,287 –
17 AXSM AXSOME THERAPEUTICS INC Healthcare 2.0%$8.2m91,721 –
18 NVO NOVO-NORDISK A S Healthcare 1.9%$8.0m67,257 –
19 KRRO KORRO BIO INC Healthcare 0.5%$2.1m64,014 –
20 FEMY FEMASYS INC 0.0%$34.0k30,606 –

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.